Patents by Inventor Michael Wormstone

Michael Wormstone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Intraocular devices
    Patent number: 11958927
    Abstract: Described herein are methods of stereolithographically printing intraocular devices, in particular intraocular lenses, as well as stereolithographic compositions for use therein. The stereolithography composition may comprise: a photoinitiator; a monofunctional aryl acrylate monomer, wherein the acrylate group of the monofunctional aryl acrylate monomer is of the formula -0-(C?0)-CH?CH2; and a multifunctional methacrylate or acrylate cross-linker, wherein the monofunctional aryl acrylate monomer is present in the composition in a greater amount than the multifunctional methacrylate or acrylate cross-linker.
    Type: Grant
    Filed: September 5, 2019
    Date of Patent: April 16, 2024
    Assignee: UEA Enterprises, Limited
    Inventors: Aram Saeed, Michael Wormstone
  • Intraocular Devices
    Publication number: 20210198408
    Abstract: Described herein are methods of stereolithographically printing intraocular devices, in particular intraocular lenses, as well as stereolithographic compositions for use therein. The stereolithography composition may comprise: a photoinitiator; a mono-functional aryl acrylate monomer, wherein the acrylate group of the monofunctional aryl acrylate monomer is of the formula —0—(C?0)—CH?CH2; and a multifunctional methacrylate or acrylate cross-linker, wherein the monofunctional aryl acrylate monomer is present in the composition in a greater amount than the multifunctional methacrylate or acrylate cross-linker.
    Type: Application
    Filed: September 5, 2018
    Publication date: July 1, 2021
    Inventors: Aram Saeed, Michael Wormstone
  • Use of calcium intracellular store inactivators and formulations thereof as cell growth inhibitors
    Patent number: 6255338
    Abstract: The use of a calcium intracellular store inactivator for inhibiting cell growth is disclosed; for example, thapsigargin or a derivative may be used to inhibit intraocular lens cell growth. Formulations include an emulsion of the compound for coating an IOL, either ex vivo or in vivo.
    Type: Grant
    Filed: June 29, 1998
    Date of Patent: July 3, 2001
    Assignees: The University of East Anglia, The Norfolk & Norwich Health Care NHS Trust
    Inventors: George Duncan, Michael Wormstone, Peter Davies, Christopher Liu